CPI is planned for nurses by nurses...
The APNA Clinical Psychopharmacology Institute (CPI) presents a state-of-the-science understanding of dimensions of psychopharmacologic nursing practice across the lifespan. The Institute focuses on complex clinical issues, addressing the most current practices and insights in clinical psychopharmacology.
The complexity of unique illness states or populations requires unique approaches that are more personal and consider the context and environments of persons you serve. CPI is unique in that it is a tailored specifically for psychiatric-mental health nurses by those who know their needs best – psychiatric-mental health nurses themselves.
The program goes beyond presenting medication algorithms and instead offers the scientific base from which treatment decisions are made, while also addressing aspects informing the context of care within the nurse/consumer/family relationship.
|“For reliable, thought provoking, cutting-edge information with resources to have on hand, The APNA Clinical Psychopharmacology Institute is, by far, the very best!”
– Joan E. Schaper, MSN, APN
You will benefit from…
- Up to 21 contact hours in pharmacology
- Access to online session recordings for a full year. Earn contact hours for what you did not attend! (Available 2-3 months afterwards)
- Opportunities to chat and connect with peers
- Digital session handouts with resources and references to explore
- Access to industry stakeholders who value the work of PMH nurses
You will get in-depth updates on…
- New medications for ADHD and treatment across the lifespan
- Clozapine’s unique mechanisms of action and practical tips for its use
- Treating stress and alcohol misuse during COVID-19
- Relationship-building around use of Long-Acting Injectables
- Prescribing guidelines when using telepsychiatry with adults and children
- A structured approach to the de-prescribing process
- The physiological impact of chronic and COVID-19 stress on elders
|Who should attend?
Advanced practice clinicians, clinical educators, psychiatric-mental health nurses, and other mental health professionals, especially those who administer and/or prescribe medications and are interested in enhancing their knowledge about the vast and rapidly growing developments in clinical psychopharmacology.